| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +201.6% |
| Cost of Revenue | $2.7M | -14.5% |
| Gross Profit | $1.2M | +150.6% |
| R&D Expense | $24K | -91.1% |
| SG&A Expense | $35.7M | -9.8% |
| Net Income | -$68.2M | -38.0% |
| EPS (Basic) | -$17.02 | -1770.3% |
| EPS (Diluted) | -$17.02 | -1770.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $55K | +0.0% |
| Accounts Receivable | $90K | +7.9% |
| Inventory | $949K | +306.5% |
| Current Assets | $6.0M | +134.2% |
| Total Assets | $41.0M | +458.3% |
| Current Liabilities | $6.0M | -36.4% |
| Total Liabilities | $6.0M | -37.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $87K | +0.0% |
| Investing Cash Flow | $5.8M | — |
| Financing Cash Flow | $21.4M | +37.0% |
| $35.0M |
| +1710.5% |